Clinical Trials
- Diabetes
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
- Ages10 years - 17 years
- GenderBoth
- Date05/21/2021
- Immune System
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)
- Ages18 years - 75 years
- GenderBoth
- Date04/27/2021
- Orthopaedics, Muscle & Bone
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus (PHOENYCS GO)
- Ages16 years and older
- GenderBoth
- Date03/25/2022
- Orthopaedics, Muscle & Bone, Immune System
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis (REGENCY)
- Ages18 years - 75 years
- GenderBoth
- Date09/14/2021
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention Study
- Ages1 year - 45 years
- GenderBoth
- Date09/16/2006
- Immune System
Yale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-Repository
- Ages18 years and older
- GenderBoth
- Date10/01/2016
- Heart/Cardiovascular
Ertugliflozin in Acute Heart Failure
- Ages18 years and older
- GenderBoth
- Date06/23/2020
- Children's Health, Diabetes
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
- Ages7 years - 75 years
- GenderBoth
- Date08/15/2019
- Diabetes
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer) A Proof-of-Concept Study
- Ages7 years - 17 years
- GenderBoth
- Date07/15/2020
- Kidney & Urinary Tract
The Impact of Phosphate Metabolism on Healthy Aging
- Ages13 years and older
- GenderBoth
- Date12/03/2019